Comparison of toric Implantabe Contact Lens (ICL) with toric Implantable Phakic Contact lens (IPCL)

Comparative evaluation of clinical outcomes of toric Implantabe Contact Lens (ICL) versus toric Implantable Phakic Contact lens (IPCL)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019157

Enrollment

Registered

2019-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: Toric ICL: Group 1: Intervention2: IPCL: Group 2: 20 eyes will undergo toric IPCL implantation Control Intervention1: ICL: Group 1: 20 eyes will undergo toric ICL implantation

Eligibility

Inclusion criteria

Inclusion criteria: 40 eyes, with high myopia and regular corneal astigmatism more than 1.25 D

Exclusion criteria

Exclusion criteria: a) Presence of other associated ocular co-morbidities such as glaucoma, uveitis, or any posterior segment pathology. b) Patients with irregular corneal astigmatism due to corneal scarring or other corneal abnormalities c) Patient not willing to participate or follow up in the study

Design outcomes

Primary

Measure	Time frame
1. Postoperative emmetropia 2. Phakic lens stability Timepoint: Baseline, 1 week, 1 month, 3 months and at 6 months	—

Secondary

Measure	Time frame
1. Post operative higher order aberrations 2. Contrast sensitivity and glare acuity 3. Endothelial cell status 4. Intraocular pressureTimepoint: Baseline, 1 week, 1 month, 3 months and at 6 months	—

Countries

India

Contacts

Public ContactNamrata Sharma

namrata.sharma@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026